CN Stock MarketDetailed Quotes

300122 Chongqing Zhifei Biological Products

Watchlist
  • 24.96
  • -0.21-0.83%
Market Closed Jan 9 15:00 CST
59.75BMarket Cap16.19P/E (TTM)

Chongqing Zhifei Biological Products Key Stats

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
-41.98%22.79B
-25.31%18.26B
2.00%11.4B
38.30%52.92B
41.15%39.27B
33.19%24.45B
26.37%11.17B
24.83%38.26B
27.46%27.82B
39.34%18.35B
Operating revenue
-41.98%22.79B
-25.31%18.26B
2.00%11.4B
38.30%52.92B
41.15%39.27B
33.19%24.45B
26.37%11.17B
24.83%38.26B
27.46%27.82B
39.34%18.35B
Other operating revenue
----
4,427.67%115.66M
----
5.86%4.08M
----
18.55%2.55M
----
-83.58%3.85M
----
-84.84%2.15M
Total operating cost
-36.80%19.69B
-20.24%15.28B
8.45%9.32B
48.35%43.09B
47.80%31.15B
38.69%19.16B
32.19%8.6B
57.31%29.05B
78.26%21.07B
107.35%13.82B
Operating cost
-41.14%16.58B
-22.23%13.39B
8.22%8.43B
52.29%38.67B
51.56%28.17B
41.00%17.22B
32.79%7.79B
62.56%25.4B
85.16%18.59B
122.40%12.21B
Operating tax surcharges
-36.33%111.44M
-20.56%88.92M
0.96%50.14M
34.87%238.75M
37.39%175.03M
31.81%111.93M
35.60%49.66M
30.90%177.02M
30.75%127.39M
36.93%84.92M
Operating expense
4.95%1.94B
-5.90%1.12B
10.83%495.13M
24.04%2.77B
25.56%1.84B
24.71%1.19B
23.18%446.75M
21.82%2.24B
19.91%1.47B
22.18%950.67M
Administration expense
12.23%306.96M
10.60%202.93M
38.95%110.95M
5.05%393.03M
-0.85%273.5M
6.87%183.49M
10.80%79.85M
24.63%374.13M
37.30%275.84M
33.03%171.7M
Financial expense
54.26%54.31M
-6.35%20.59M
-69.57%5.96M
242.20%47.22M
379.40%35.21M
217.72%21.99M
178.72%19.6M
-36.77%13.8M
-62.63%7.34M
-82.34%6.92M
-Interest expense (Financial expense)
45.30%83.71M
24.11%49.23M
15.25%24.48M
51.98%81M
37.45%57.61M
41.25%39.66M
138.10%21.24M
-5.07%53.3M
-22.39%41.91M
-43.40%28.08M
-Interest Income (Financial expense)
-22.63%-57.76M
-52.04%-47.18M
-125.95%-29.66M
-47.40%-67.94M
-36.55%-47.1M
-44.64%-31.03M
-7.40%-13.13M
25.01%-46.09M
20.18%-34.49M
-33.32%-21.45M
Research and development
7.25%695.55M
5.60%461.35M
9.41%234.08M
13.38%968.47M
6.76%648.54M
12.68%436.88M
32.98%213.96M
54.56%854.16M
152.77%607.5M
138.26%387.72M
Credit Impairment Loss
-6.56%-605.07M
-25.14%-396.67M
-126.58%-340.79M
16.32%-352.71M
-122.44%-567.84M
-58.63%-316.98M
-11.84%-150.41M
-120.78%-421.51M
-59.90%-255.28M
-78.87%-199.83M
Asset Impairment Loss
77.07%-26.4M
80.88%-12.01M
97.03%-1.03M
-186.58%-311.99M
-264.91%-115.14M
-620.30%-62.79M
-223.84%-34.59M
-17.67%-108.87M
-567.91%-31.55M
-114.80%-8.72M
Other net revenue
-25.73%-615.71M
-25.38%-397.6M
-87.50%-335.67M
1.28%-449.97M
-109.96%-489.7M
-93.03%-317.11M
-161.21%-179.02M
-145.10%-455.79M
-75.71%-233.24M
-56.25%-164.28M
Asset deal income
-99.87%54.24K
-99.78%95.41K
----
618,276.31%41.37M
280,967.56%43.05M
281,852.30%43.19M
--41.78K
-82.90%6.69K
-14.47%15.32K
-14.47%15.32K
Other revenue
-89.54%15.71M
-43.60%10.99M
3.78%6.16M
132.43%173.36M
180.39%150.23M
-55.98%19.48M
-84.40%5.93M
-27.63%74.59M
38.41%53.58M
166.73%44.25M
Operating profit
-67.46%2.48B
-48.08%2.58B
-27.54%1.74B
7.02%9.37B
17.18%7.64B
13.57%4.97B
5.62%2.4B
-27.01%8.76B
-34.01%6.52B
-31.69%4.37B
Add:Non operating Income
138.62%38.09K
218.68%38.09K
83.63%18.52K
-44.80%337.69K
-89.19%15.96K
-91.29%11.95K
681.73%10.09K
230.76%611.76K
73.93%147.64K
191.58%137.18K
Less:Non operating expense
-59.53%6.79M
26.00%6.46M
-36.55%2.92M
-23.18%31.48M
-50.39%16.79M
-75.46%5.12M
-27.15%4.6M
-40.69%40.98M
-30.89%33.84M
-16.76%20.88M
Total profit
-67.48%2.48B
-48.16%2.57B
-27.53%1.73B
7.16%9.34B
17.53%7.62B
13.99%4.96B
5.71%2.39B
-26.93%8.72B
-34.02%6.48B
-31.75%4.35B
Less:Income tax cost
-69.94%327.33M
-51.83%338.38M
-23.38%276.02M
7.92%1.27B
24.37%1.09B
12.55%702.41M
5.89%360.26M
-31.55%1.18B
-38.42%875.41M
-29.69%624.11M
Net profit
-67.07%2.15B
-47.55%2.23B
-28.26%1.46B
7.04%8.07B
16.46%6.53B
14.24%4.26B
5.68%2.03B
-26.15%7.54B
-33.28%5.61B
-32.08%3.73B
Net profit from continuing operation
-67.07%2.15B
-47.55%2.23B
-28.26%1.46B
7.04%8.07B
16.46%6.53B
14.24%4.26B
5.68%2.03B
-26.15%7.54B
-33.28%5.61B
-32.08%3.73B
Net profit of parent company owners
-67.07%2.15B
-47.55%2.23B
-28.26%1.46B
7.04%8.07B
16.46%6.53B
14.24%4.26B
5.68%2.03B
-26.15%7.54B
-33.28%5.61B
-32.08%3.73B
Earning per share
Basic earning per share
-67.01%0.8976
-47.48%0.9322
-28.07%0.609
7.04%3.3624
16.47%2.721
14.24%1.775
-29.54%0.8467
-50.77%3.1412
-55.52%2.3363
-54.72%1.5538
Diluted earning per share
-67.01%0.8976
-47.48%0.9322
-28.07%0.609
7.04%3.3624
16.47%2.721
14.24%1.775
-29.54%0.8467
-50.77%3.1412
-55.52%2.3363
-54.72%1.5538
Other composite income
Total composite income
-67.07%2.15B
-47.55%2.23B
-28.26%1.46B
7.04%8.07B
16.46%6.53B
14.24%4.26B
5.68%2.03B
-26.15%7.54B
-33.28%5.61B
-32.08%3.73B
Total composite income of parent company owners
-67.07%2.15B
-47.55%2.23B
-28.26%1.46B
7.04%8.07B
16.46%6.53B
14.24%4.26B
5.68%2.03B
-26.15%7.54B
-33.28%5.61B
-32.08%3.73B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)
--
--
--
Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)
--
--
(Q9)Sep 30, 2024 (Q6)Jun 30, 2024 (Q3)Mar 31, 2024 (FY)Dec 31, 2023 (Q9)Sep 30, 2023 (Q6)Jun 30, 2023 (Q3)Mar 31, 2023 (FY)Dec 31, 2022 (Q9)Sep 30, 2022 (Q6)Jun 30, 2022
Total operating revenue -41.98%22.79B -25.31%18.26B 2.00%11.4B 38.30%52.92B 41.15%39.27B 33.19%24.45B 26.37%11.17B 24.83%38.26B 27.46%27.82B 39.34%18.35B
Operating revenue -41.98%22.79B -25.31%18.26B 2.00%11.4B 38.30%52.92B 41.15%39.27B 33.19%24.45B 26.37%11.17B 24.83%38.26B 27.46%27.82B 39.34%18.35B
Other operating revenue ---- 4,427.67%115.66M ---- 5.86%4.08M ---- 18.55%2.55M ---- -83.58%3.85M ---- -84.84%2.15M
Total operating cost -36.80%19.69B -20.24%15.28B 8.45%9.32B 48.35%43.09B 47.80%31.15B 38.69%19.16B 32.19%8.6B 57.31%29.05B 78.26%21.07B 107.35%13.82B
Operating cost -41.14%16.58B -22.23%13.39B 8.22%8.43B 52.29%38.67B 51.56%28.17B 41.00%17.22B 32.79%7.79B 62.56%25.4B 85.16%18.59B 122.40%12.21B
Operating tax surcharges -36.33%111.44M -20.56%88.92M 0.96%50.14M 34.87%238.75M 37.39%175.03M 31.81%111.93M 35.60%49.66M 30.90%177.02M 30.75%127.39M 36.93%84.92M
Operating expense 4.95%1.94B -5.90%1.12B 10.83%495.13M 24.04%2.77B 25.56%1.84B 24.71%1.19B 23.18%446.75M 21.82%2.24B 19.91%1.47B 22.18%950.67M
Administration expense 12.23%306.96M 10.60%202.93M 38.95%110.95M 5.05%393.03M -0.85%273.5M 6.87%183.49M 10.80%79.85M 24.63%374.13M 37.30%275.84M 33.03%171.7M
Financial expense 54.26%54.31M -6.35%20.59M -69.57%5.96M 242.20%47.22M 379.40%35.21M 217.72%21.99M 178.72%19.6M -36.77%13.8M -62.63%7.34M -82.34%6.92M
-Interest expense (Financial expense) 45.30%83.71M 24.11%49.23M 15.25%24.48M 51.98%81M 37.45%57.61M 41.25%39.66M 138.10%21.24M -5.07%53.3M -22.39%41.91M -43.40%28.08M
-Interest Income (Financial expense) -22.63%-57.76M -52.04%-47.18M -125.95%-29.66M -47.40%-67.94M -36.55%-47.1M -44.64%-31.03M -7.40%-13.13M 25.01%-46.09M 20.18%-34.49M -33.32%-21.45M
Research and development 7.25%695.55M 5.60%461.35M 9.41%234.08M 13.38%968.47M 6.76%648.54M 12.68%436.88M 32.98%213.96M 54.56%854.16M 152.77%607.5M 138.26%387.72M
Credit Impairment Loss -6.56%-605.07M -25.14%-396.67M -126.58%-340.79M 16.32%-352.71M -122.44%-567.84M -58.63%-316.98M -11.84%-150.41M -120.78%-421.51M -59.90%-255.28M -78.87%-199.83M
Asset Impairment Loss 77.07%-26.4M 80.88%-12.01M 97.03%-1.03M -186.58%-311.99M -264.91%-115.14M -620.30%-62.79M -223.84%-34.59M -17.67%-108.87M -567.91%-31.55M -114.80%-8.72M
Other net revenue -25.73%-615.71M -25.38%-397.6M -87.50%-335.67M 1.28%-449.97M -109.96%-489.7M -93.03%-317.11M -161.21%-179.02M -145.10%-455.79M -75.71%-233.24M -56.25%-164.28M
Asset deal income -99.87%54.24K -99.78%95.41K ---- 618,276.31%41.37M 280,967.56%43.05M 281,852.30%43.19M --41.78K -82.90%6.69K -14.47%15.32K -14.47%15.32K
Other revenue -89.54%15.71M -43.60%10.99M 3.78%6.16M 132.43%173.36M 180.39%150.23M -55.98%19.48M -84.40%5.93M -27.63%74.59M 38.41%53.58M 166.73%44.25M
Operating profit -67.46%2.48B -48.08%2.58B -27.54%1.74B 7.02%9.37B 17.18%7.64B 13.57%4.97B 5.62%2.4B -27.01%8.76B -34.01%6.52B -31.69%4.37B
Add:Non operating Income 138.62%38.09K 218.68%38.09K 83.63%18.52K -44.80%337.69K -89.19%15.96K -91.29%11.95K 681.73%10.09K 230.76%611.76K 73.93%147.64K 191.58%137.18K
Less:Non operating expense -59.53%6.79M 26.00%6.46M -36.55%2.92M -23.18%31.48M -50.39%16.79M -75.46%5.12M -27.15%4.6M -40.69%40.98M -30.89%33.84M -16.76%20.88M
Total profit -67.48%2.48B -48.16%2.57B -27.53%1.73B 7.16%9.34B 17.53%7.62B 13.99%4.96B 5.71%2.39B -26.93%8.72B -34.02%6.48B -31.75%4.35B
Less:Income tax cost -69.94%327.33M -51.83%338.38M -23.38%276.02M 7.92%1.27B 24.37%1.09B 12.55%702.41M 5.89%360.26M -31.55%1.18B -38.42%875.41M -29.69%624.11M
Net profit -67.07%2.15B -47.55%2.23B -28.26%1.46B 7.04%8.07B 16.46%6.53B 14.24%4.26B 5.68%2.03B -26.15%7.54B -33.28%5.61B -32.08%3.73B
Net profit from continuing operation -67.07%2.15B -47.55%2.23B -28.26%1.46B 7.04%8.07B 16.46%6.53B 14.24%4.26B 5.68%2.03B -26.15%7.54B -33.28%5.61B -32.08%3.73B
Net profit of parent company owners -67.07%2.15B -47.55%2.23B -28.26%1.46B 7.04%8.07B 16.46%6.53B 14.24%4.26B 5.68%2.03B -26.15%7.54B -33.28%5.61B -32.08%3.73B
Earning per share
Basic earning per share -67.01%0.8976 -47.48%0.9322 -28.07%0.609 7.04%3.3624 16.47%2.721 14.24%1.775 -29.54%0.8467 -50.77%3.1412 -55.52%2.3363 -54.72%1.5538
Diluted earning per share -67.01%0.8976 -47.48%0.9322 -28.07%0.609 7.04%3.3624 16.47%2.721 14.24%1.775 -29.54%0.8467 -50.77%3.1412 -55.52%2.3363 -54.72%1.5538
Other composite income
Total composite income -67.07%2.15B -47.55%2.23B -28.26%1.46B 7.04%8.07B 16.46%6.53B 14.24%4.26B 5.68%2.03B -26.15%7.54B -33.28%5.61B -32.08%3.73B
Total composite income of parent company owners -67.07%2.15B -47.55%2.23B -28.26%1.46B 7.04%8.07B 16.46%6.53B 14.24%4.26B 5.68%2.03B -26.15%7.54B -33.28%5.61B -32.08%3.73B
Currency Unit CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY
Accounting Standards CAS (2007) CAS (2007) CAS (2007) CAS (2007) CAS (2007) CAS (2007) CAS (2007) CAS (2007) CAS (2007) CAS (2007)
Audit Opinions -- -- -- Unqualified opinion -- -- -- Unqualified opinion -- --
Auditor -- -- -- Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) -- -- -- Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) -- --

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data